Sen. Collins Discusses Medical Supply Chain, Type I Diabetes Therapies With FDA Nominee
December 18, 2021
December 18, 2021
WASHINGTON, Dec. 18 -- Sen. Susan M. Collins, R-Maine, issued the following news release:
U.S. Senator Susan Collins, a member of the Senate Health Committee, questioned Dr. Robert Califf at a hearing to consider his nomination to serve as Commissioner of the Food and Drug Administration (FDA).
Senator Collins commended Dr. Califf's pledge to improve the FDA's preparedness for future public health emergencies if he were confirmed to lead the agency. She remark . . .
U.S. Senator Susan Collins, a member of the Senate Health Committee, questioned Dr. Robert Califf at a hearing to consider his nomination to serve as Commissioner of the Food and Drug Administration (FDA).
Senator Collins commended Dr. Califf's pledge to improve the FDA's preparedness for future public health emergencies if he were confirmed to lead the agency. She remark . . .